Adicet Bio Inc (ACET)

Feb 18, 2025

Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com Nigeria

Feb 18, 2025

Feb 17, 2025

Adicet Bio's SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com

Feb 17, 2025

Feb 13, 2025

Healthy Upside Potential: Adicet Bio Inc (ACET) - SETE News

Feb 13, 2025

Feb 10, 2025

Adicet Bio Inc [ACET] Insider Activity: An Update for Investors - Knox Daily

Feb 10, 2025

Feb 10, 2025

Investor Alert: What’s Really Going On At Adicet Bio Inc (NASDAQ: ACET) - Stocks Register

Feb 10, 2025

Feb 10, 2025

Adicet Bio (NASDAQ:ACET) Earns Market Perform Rating from JMP Securities - MarketBeat

Feb 10, 2025

Feb 09, 2025

Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $7.50 - MarketBeat

Feb 09, 2025

Feb 09, 2025

Adicet Bio reports progress in clinical trial enrollments - MSN

Feb 09, 2025

Feb 09, 2025

HC Wainwright Reaffirms Neutral Rating for Adicet Bio (NASDAQ:ACET) - MarketBeat

Feb 09, 2025

Feb 08, 2025

Adicet Bio (NASDAQ:ACET) Earns “Market Perform” Rating from JMP Securities - Defense World

Feb 08, 2025

Feb 07, 2025

Top investors say Adicet Bio Inc (ACET) ticks everything they need - SETE News

Feb 07, 2025

Feb 07, 2025

Major Win – FDA Grants Fast Track Designation to Adicet Bio’s ADI-001 for Lupus Disease - geneonline

Feb 07, 2025

Feb 07, 2025

Adicet Bio (NASDAQ:ACET) Earns “Neutral” Rating from HC Wainwright - Defense World

Feb 07, 2025

Feb 06, 2025

Adicet Bio Inc [NASDAQ: ACET] Sees Increase in Stock Value - Knox Daily

Feb 06, 2025

Feb 05, 2025

Adicet Bio reports progress in clinical trial enrollments By Investing.com - Investing.com Australia

Feb 05, 2025

Feb 05, 2025

Adicet Bio Inc (ACET) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Feb 05, 2025

Feb 05, 2025

Adicet Bio Inc (ACET) Stock Price and Analyst Predictions - The News Heater

Feb 05, 2025

Feb 05, 2025

What is ACET’s price-to-sales ratio telling us about the company’s value? - US Post News

Feb 05, 2025

Feb 05, 2025

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement - Marketscreener.com

Feb 05, 2025

Feb 05, 2025

Revolutionary Lupus Treatment Gets FDA Fast-Track: Adicet's ADI-001 Could Transform Patient Care - StockTitan

Feb 05, 2025

Feb 03, 2025

JPMorgan Chase & Co. Boosts Stock Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

Feb 03, 2025

Jan 31, 2025

Adicet Bio Sparks Excitement with Major Stock Options Award for New Hires! - Mi Valle

Jan 31, 2025

Jan 31, 2025

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jan 31, 2025

Jan 31, 2025

Adicet's New CMO Receives 750,000 Share Options Package as Company Bolsters Leadership - StockTitan

Jan 31, 2025

Jan 29, 2025

Adicet Bio doses first subject in Phase I trial of renal cell carcinoma therapy - MSN

Jan 29, 2025

Jan 29, 2025

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference - Business Wire

Jan 29, 2025

Jan 26, 2025

HC Wainwright & Co. Downgrades Adicet Bio (ACET) - MSN

Jan 26, 2025

Jan 15, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Shares Sold by Jane Street Group LLC - Defense World

Jan 15, 2025

Jan 10, 2025

Geode Capital Management LLC Increases Position in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

Jan 10, 2025

Jan 08, 2025

Adicet Bio Provides Corporate Update - TradingView

Jan 08, 2025

Jan 08, 2025

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones - Business Wire

Jan 08, 2025

Jan 08, 2025

Adicet Bio Advances First Gamma Delta CAR T Cell Therapy for Solid Tumors, Expands Autoimmune Trial - StockTitan

Jan 08, 2025

Jan 04, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Stake Reduced by State Street Corp - Defense World

Jan 04, 2025

Dec 31, 2024

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 31, 2024

Dec 31, 2024

Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World

Dec 31, 2024

Dec 28, 2024

Adicet Bio (NASDAQ:ACET) Stock Passes Below 200-Day Moving Average – Time to Sell? - Defense World

Dec 28, 2024

Dec 28, 2024

Adicet Bio (NASDAQ:ACET) Stock Price Crosses Below 200 Day Moving AverageWhat's Next? - MarketBeat

Dec 28, 2024

Dec 26, 2024

ACET Founder Acme Proposes Using Bitcoin Integration to Transform Thailand Economy - GlobeNewswire Inc.

Dec 26, 2024

Dec 21, 2024

Adicet Bio (NASDAQ:ACET) Earns Neutral Rating from HC Wainwright - Defense World

Dec 21, 2024

Dec 20, 2024

Adicet Bio, Inc. (NASDAQ:ACET) Shares Bought by Fmr LLC - Defense World

Dec 20, 2024

Dec 20, 2024

Adicet Bio begins trial for kidney cancer therapy By Investing.com - Investing.com Canada

Dec 20, 2024

Dec 19, 2024

Adicet Bio Advances with Phase 1 Trial of ADI-270 - TipRanks

Dec 19, 2024

Dec 19, 2024

Adicet Bio (NASDAQ:ACET) Receives Neutral Rating from HC Wainwright - MarketBeat

Dec 19, 2024

Dec 19, 2024

Adicet Bio begins trial for kidney cancer therapy - Investing.com

Dec 19, 2024

Dec 19, 2024

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma - BioSpace

Dec 19, 2024

Dec 19, 2024

ACET stock touches 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa

Dec 19, 2024

Dec 19, 2024

ACET stock touches 52-week low at $0.89 amid market challenges - Investing.com Canada

Dec 19, 2024

Dec 18, 2024

Adicet Bio names new Chief Medical Officer By Investing.com - Investing.com Australia

Dec 18, 2024